Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 SEK | +3.75% | 0.00% | +27.30% |
08:30am | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.30% | 16.14M | |
+2.52% | 92.1B | |
-2.63% | 37.92B | |
-12.39% | 32.97B | |
+75.60% | 27.92B | |
-11.20% | 16.14B | |
-1.64% | 14.1B | |
-11.93% | 11.66B | |
+177.66% | 10.29B | |
-50.94% | 9.99B |
- Stock Market
- Equities
- LIPUM Stock
- News Lipum AB
- Lipum Obtains Regulatory Approval in Netherlands for Clinical Trial of Rheumatoid Arthritis Drug